Logo image
Urine Injury Biomarkers Are Not Associated With Kidney Transplant Failure
Journal article   Open access   Peer reviewed

Urine Injury Biomarkers Are Not Associated With Kidney Transplant Failure

Neel Koyawala, Peter P Reese, Isaac E Hall, Yaqi Jia, Heather R Thiessen-Philbrook, Sherry G Mansour, Mona D Doshi, Enver Akalin, Jonathan S Bromberg, Meera N Harhay, …
Transplantation, v 104(6), pp 1272-1279
Jun 2020
PMID: 31568213
url
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384615View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Acute Kidney Injury - diagnosis Acute Kidney Injury - physiopathology Acute Kidney Injury - urine Adult Aged Allografts - physiopathology Biomarkers - urine Creatinine - urine Female Follow-Up Studies Glomerular Filtration Rate - physiology Graft Rejection - epidemiology Graft Rejection - etiology Graft Rejection - physiopathology Humans Kidney - physiopathology Kidney Failure, Chronic - mortality Kidney Failure, Chronic - surgery Kidney Transplantation - adverse effects Male Middle Aged Tissue Donors Treatment Outcome
Kidneys transplanted from deceased donors with serum creatinine-defined acute kidney injury (AKI) have similar allograft survival as non-AKI kidneys but are discarded at a higher rate. Urine injury biomarkers are sensitive markers of structural kidney damage and may more accurately predict graft outcomes. In the 2010-2013 multicenter Deceased Donor Study of 2430 kidney transplant recipients from 1298 donors, we assessed the association of donor urine injury biomarkers microalbumin, neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, IL-18, and liver-type fatty acid binding protein with graft failure (GF) and death-censored GF (dcGF) using Cox proportional hazard models (median follow-up 4 y). We examined if serum creatinine-defined donor AKI modified this association to assess the relationship between subclinical donor AKI (elevated biomarkers without creatinine-defined AKI) and GF. Through chart review of a subcohort (1137 recipients), we determined associations between donor injury biomarkers and a 3-year composite outcome of GF, mortality, or estimated glomerular filtration rate ≤ 20mL/min/1.73m. Risk of GF, dcGF, and 3-year composite outcome did not vary with donor injury biomarker concentrations after adjusting for donor, transplant, and recipient characteristics (adjusted hazard ratio ranged from 0.96 to 1.01 per log-2 increase in biomarker). Subclinical injury in transplanted kidneys without AKI was not associated with GF. AKI measured using injury biomarkers was not associated with posttransplant graft outcomes (at median 4 y posttransplant). When assessing posttransplant graft viability, clinicians can prioritize other donor and recipient factors over donor kidney injury, measured by either serum creatinine or urine injury biomarkers.

Metrics

13 Record Views
13 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Immunology
Surgery
Transplantation
Logo image